Home / Press Release / Global Botulinum Toxin Market Expected To Reach US$ Xx Mn By 2026

Global Botulinum Toxin Market Expected To Reach US$ Xx Mn By 2026

The latest market report published by Credence Research, Inc. “Botulinum toxin Market Growth, Future Prospects, and Competitive Analysis, 2018 - 2026” the botulinum toxin market was valued at US$ 3,672.4 Mn in 2017 and expected to grow at a CAGR of 7.2 % during the forecast period from 2018 to 2026.

Browse the full report Botulinum Toxin Market Growth, Future Prospects, and Competitive Analysis, 2018 - 2026 at  https://www.credenceresearch.com/report/botulinum-toxin-market

Market Insights

The global botulinum toxin market shows productive growth during the forecast period from 2018 to 2026, attributed to its wide usage in cosmetic and therapeutic applications. Common types are botulinum toxin A (BNT-A), and botulinum toxin B (BNT-B). Botox injections or drugs made from a neurotoxin produced by the bacterium clostridium botulinum. Doctors or dermatology specialists use botulinum toxins in very small doses to treat numerous health problems such as smoothing of facial wrinkles, cervical dystonia (neurological disorder), blepharospasm, overactive bladder, upper limb or lower limb spasticity, strabismus, tremor, hypersecretory disorders and others. BNT Type A trade names in the U.S. are mainly sold as Botox, Dysport and Xeomin (commercially available) and type B trade names are Myobloc and Neurobloc. Botulinum toxin B is U.S FDA approved for treatment against cervical dystonia and hemifacial spasm (HFS).

Consistent innovation along with top cosmetic applications to give productive restorative intervention to a large group of diseases has supported the overall growth of the market. A few botulinum toxins (BNT) are in clinical stage and anticipated to drive the market in the coming years. The prominent growth factors include increasing cosmetic and therapeutic procedures worldwide, FDA approval of botulinum treatments, higher efficacy, increasing geriatric population, increasing awareness, offers potential advantage as an elective treatment to high cost medical/surgical procedures, and wide usage of top applications in the cosmetic industry.

In any case, safety issues in treatment and in general potential lethality, high financial investment and expensive medications, strict administrative rules, and reimbursement approach issues are the key components limiting the market growth during the forecast period. In addition, the worldwide monetary conditions in the healthcare sector in developing economies make a noteworthy open door for the extension of the market.

Key Market Movements:

Contact Information
24/7 Research Support
Phone: +1-800-361-8290
sales@credenceresearch.com
Get in Touch with us
Join us on Facebook
Follow us on Twitter
Join us on LinkedIn
Add us on Google +